Integrating Liquid Biopsy and Radiomics to Monitor Clonal Heterogeneity of EGFR-Positive Non-Small Cell Lung Cancer

BackgroundEGFR-positive Non-small Cell Lung Cancer (NSCLC) is a dynamic entity and tumor progression and resistance to tyrosine kinase inhibitors (TKIs) arise from the accumulation, over time and across different disease sites, of subclonal genetic mutations. For instance, the occurrence of EGFR T79...

Full beskrivning

Bibliografiska uppgifter

Huvudupphov:	Federico Cucchiara, Marzia Del Re, Simona Valleggi, Chiara Romei, Iacopo Petrini, Maurizio Lucchesi, Stefania Crucitta, Eleonora Rofi, Annalisa De Liperi, Antonio Chella, Antonio Russo, Romano Danesi
Materialtyp:	Artigo
Språk:	Inglês
Utgiven:	Frontiers Media S.A. 2020-12-01
Serie:	Frontiers in Oncology
Ämnen:	non-small cell lung cancer EGFR liquid biopsy cell free DNA radiomics tyrosine kinase inhibitors
Länkar:	https://www.frontiersin.org/articles/10.3389/fonc.2020.593831/full
Taggar:	Lägg till en tagg Inga taggar, Lägg till första taggen!